Showing results (361-370 of 1,558) with videos related to
Sort By:
Pageof 156
Alimentary Pharmacology & Therapeutics|August 19, 2016
Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitisL Peyrin-Biroulet, A Germain, A S Patel, et al.Analytical Chemistry|May 22, 2007
Aptamer-based enantioselective competitive binding assay for the trace enantiomer detectionJosephine Ruta, Corinne Ravelet, Isabelle Baussanne, et al.United European Gastroenterology Journal|September 16, 2022
Landscape of new drugs and targets in inflammatory bowel diseaseSophie Vieujean, Ferdinando D'Amico, Patrick Netter, et al.Pharmacology & Therapeutics|January 26, 2016
Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseasesCaroline Meyer Olesen, Mehmet Coskun, Laurent Peyrin-Biroulet, et al.Journal of Agricultural and Food Chemistry|January 5, 2016
Sodium Chloride Diffusion during Muscle Salting Evidenced by Energy-Dispersive X-ray Spectroscopy ImagingRénata Filgueras, Frédéric Peyrin, Annie Vénien, et al.Lancet (London, England)|July 8, 2008
Crohn's disease: beyond antagonists of tumour necrosis factorLaurent Peyrin-Biroulet, Pierre Desreumaux, William J Sandborn, et al.Nature Reviews. Gastroenterology & Hepatology|January 20, 2019
Big data in IBD: a look into the futurePablo Olivera, Silvio Danese, Nicolas Jay, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|March 1, 1985
Free dopamine in dog plasma: lack of relationship with sympathoadrenal activityJ M Pequignot, R Favier, D Desplanches, et al.Current Drug Targets|September 4, 2020
Thrombosis in IBD in the Era of JAK InhibitionVirginia Solitano, Gionata Fiorino, Ferdinando D'Amico, et al.Expert Review of Clinical Immunology|September 21, 2020
Biosimilar switching in inflammatory bowel disease: from evidence to clinical practiceVirginia Solitano, Ferdinando D'Amico, Gionata Fiorino, et al.Pageof 156